期刊文献+

非小细胞肺癌Ki-ras基因第12位密码子突变与吸烟的关系 被引量:1

Association of mutation in codon 12 of Kiras with tobacco smoking in nonsmallcell lung cancer
下载PDF
导出
摘要 目的探讨Ki-ras基因突变在肺癌不同病理型中的分布及与吸烟的关系。方法采用聚合酶链反应-单链构象多态性分析(PCR-SSCP)检测40例肺癌病理标本Ki-ras基因第12位密码子点突变。结果检出6例突变者,突变率为15%。腺癌和鳞癌的突变率分别为17.4%(4/23)和13.3%(2/15),无显著性差异(χ2=1.43,P>0.05)。有吸烟史的肺癌突变率为6.45%(2/31),非吸烟肺癌中突变率为44.4%(4/9)。结论在非小细胞肺癌中未发现Ki-ras基因突变与吸烟有关。 Objective To study the relationship between smoking related lung cancer and mutation in codon 12 of Kiras in nonsmallcell lung cancer. Method Single strand conformation polymorphism analysis of polymerase chain reaction products (PCRSSCP) with silver staining was used to detect the mutation in codon 12 of Kiras in the paraffinembedded lung cancer tissue. Results Six of 40 cases (15 percent) were found with mutations in codon 12 of Kiras. The frequence of mutation was 17.4 percent for adenocarcinoma and 13.3 percent for squamous cell carcinoma in subtype analysis, respectively (P>0.05). The mutation was more frequent in nonsmokers (44.4%) than in smokers (6.45%). Conclusion The results failed to prove that mutation in codon 12 of Kiras mutations is associated with tobacco smoking in nonsmallcell lung cancer.
出处 《中华疾病控制杂志》 CAS 1999年第2期16-17,共2页 Chinese Journal of Disease Control & Prevention
基金 国务院侨办重点科研基金
关键词 肺癌 KI-RAS基因 吸烟 lung neoplasm Kiras oncogene smoking
  • 相关文献

同被引文献16

  • 1林东红,刘庭波,陈志哲.原位杂交检测白血病细胞表皮生长因子受体基因的表达及其临床意义[J].中国肿瘤生物治疗杂志,2006,13(1):63-64. 被引量:1
  • 2Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture [J]. Eur J Cancer, 2001,37(suppl 8) : S4-S66.
  • 3Roskoski R Jr. The ErbB/HER receptor protein-tyrosine kinases and cancer [J]. Biochem Biophys Res Commun, 2004,319( 1 ) : 1-11.
  • 4Scagliotti GV, Selvaggi G, Novello S, et al. The biology of epidermal growth factor receptor in lung cancer [J]. Clin Cancer Res,2004,10(12pt2):4227s-4232s.
  • 5Kim HG, Kassis J, Souto JC, et al. EGF receptor signaling in prostate morphogenesis and tumorigenesis [J]. Histol Histopathol, 1999,14(4) : 1175-1182.
  • 6Franklin WA, Veve R, Hirsch FR, et al. Epidermal growth factor receptor family in lung cancer and premalignancy [J]. Semin Oncol, 2002,29(1 suppl 4) :3-14.
  • 7Gutacker C, Klock G, Diel P, et al. Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells [J]. Biochem J, 1999,339(Pt3) :759-766.
  • 8Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer [J]. J Clin Oncol, 2003,21(14) :2787-2799.
  • 9Normanno N, Maiello MR, De Luca A. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) : simple drugs with a complex mechanism of action [J]. J Cell Physiol, 2003, 194(1) : 13-19.
  • 10Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatie colorectal cancer [J]. N Engl J Med, 2004,351(14) : 337-345.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部